GSK cuts jobs, invests

GSK to Cut Jobs Amid £1.9bn Cost-Cutting Plan and Bid for Faster Drug Development

GSK plans to cut over 1,000 jobs and close its Stevenage R&D site to fund a £400m investment in Cambridge, accelerating drug development in areas like oncology and vaccines.